Elicio Therapeutics, Inc. (ELTX) Institutional Ownership

Ownership Summary

Elicio Therapeutics, Inc. (NASDAQ:ELTX) is held by 37 institutional investors per 13F filings through December 2025.

• They owned 12.5% of outstanding stock in December 2025, up from 11.8% the prior quarter.
• They increased total shares held in Elicio Therapeutics by 12.16% from the prior quarter, while the number of investors in ELTX increased 105.56% year over year.
• During the quarter, 23 of these 37 funds increased positions in ELTX, 5 reduced exposure, and 9 held steady.
• Altogether, these fund groups held 2.08Mn shares in ELTX by December 2025, up by 225.45K shares quarter on quarter, and up 1.63Mn shares year over year.
• Knoll Capital Management, LLC holds the largest position in ELTX at 630.92K shares as of December 31, 2025, or 3.78% of shares outstanding.
• The largest buyers of Elicio Therapeutics for the quarter ending December 2025 were VANGUARD CAPITAL MANAGEMENT LLC (518.64K), BALYASNY ASSET MANAGEMENT L.P. (106.05K), RENAISSANCE TECHNOLOGIES LLC (93.52K), MILLENNIUM MANAGEMENT LLC (92.76K), VANGUARD FIDUCIARY TRUST CO (69.19K).
• The largest sellers of Elicio Therapeutics for the quarter ending December 2025 were MARSHALL WACE, LLP (42.69K), OMERS ADMINISTRATION Corp (12.8K), Qube Research & Technologies Ltd (7.73K), Quadrature Capital Ltd (247), Royal Bank Of Canada (196).
• Per Business Quant data, the top 10 holders of Elicio Therapeutics for the quarter ending December 2025 are Knoll Capital Management, LLC (630.92K), VANGUARD CAPITAL MANAGEMENT LLC (518.64K), BALYASNY ASSET MANAGEMENT L.P. (244.81K), GEODE CAPITAL MANAGEMENT, LLC (135.16K), RENAISSANCE TECHNOLOGIES LLC (121.63K), MILLENNIUM MANAGEMENT LLC (92.76K), MARSHALL WACE, LLP (74.51K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (70.8K), VANGUARD FIDUCIARY TRUST CO (69.19K), Northern Trust Corp (59.73K).